Sep 09, 2022
Following the changing alopecia areata treatment scenarios, DelveInsight aims to draw attention to newly approved therapy for alopecia areata.
Read More...
Sep 07, 2022
With the approval from FDA, many Digital Therapeutics products are launched in the market over the years, providing health benefits to patients
Read More...
Sep 05, 2022
To cater to the unmet need in the WHIM syndrome treatment market, leading companies across the globe are working in the therapeutics space
Read More...
Sep 02, 2022
First drug approved in primary sclerosing cholangitis treatment market by companies will have a competitive advantage in therapeutic domain.
Read More...
Aug 31, 2022
Digital Twin in Healthcare is disrupting the industry trends with its application and benefits. Companies are working on innovative solutions
Read More...
Aug 24, 2022
Nanotechnology is an evolving and innovative technology set to transform healthcare dynamics to its core with promising applications. Advancements in nanoscience have led to the emergence of a new generation of nanostructures that are employable in the healthcare industry to a much larger extent. With the unique ab...
Read More...
Aug 19, 2022
Currently, more than 70 companies are evaluating 235+ AAV vectors in gene therapy at different stages to improve the therapeutics segment.
Read More...
Aug 17, 2022
Interoperability solutions in healthcare are improving the patient experience by streamlining care delivery. Major companies in the market
Read More...
Aug 12, 2022
The expected launch of newly approved Molluscum Contagiosum therapies such as VP-102 and SB206 are expected to drive the therapeutics segment in the coming years.
Read More...
Aug 10, 2022
Globally, Telepsychiatry demand is rising at an immense pace. Key companies are working in the market to fulfill their needs. Due to various benefits, the market is
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper